Sermorelin 5mg

Sermorelin is a synthetic analogue of growth hormone-releasing hormone, typically described as the biologically active 1–29 amino acid fragment of GHRH, and has been studied in clinical and endocrine research for its ability to stimulate pituitary growth hormone release. Published literature has examined Sermorelin in both diagnostic and therapeutic contexts, including growth hormone deficiency testing and the stimulation of endogenous growth hormone secretion in selected populations (Prakash & Goa, 1999; Thorner et al., 1996; Vance et al., 1986). In research settings, Sermorelin is commonly explored in relation to somatotropic signalling, IGF-1 activity, and endocrine regulation. Supplied as a lyophilised peptide, this product is intended strictly for laboratory research use only. It is not approved for human consumption, and its clinical relevance depends heavily on the context, dose, and population being studied (Prakash & Goa, 1999).